In this first part of two episodes, Rich sits down with leaders from different parts of the BHCR to talk about what they are working on, and their thoughts on the event. His guests are Jim Jackson, SVP, CSO at Emergent BioSolutions and Jim Hughes, Vice President at University of Maryland, Baltimore.
In this second part of two episodes, Rich sits down with leaders from different parts of the BHCR to talk about what they are working on, and their thoughts on the event. His guests are Todd Haim, SBIR Director, NCI SBIR Development Center at NIH, and Matthew McMahon, Director, Office of Translational Alliances and Coordination at the National Heart, Lung, and Blood Institute at NIH
More than half of all venture capital dollars invested in small businesses and startups during the first three months of 2018 went straight into the state of California, according to a recent investment report from PwC and CB Insights suggesting the vast majority of business investment in the U.S. is concentrated in only a few states.
Rockville-based BeneVir Biopharm Inc., a biotech specializing in immunotherapy treatments for cancer, has reached a deal to sell to pharmaceutical goliath Janssen Biotech Inc., a Johnson & Johnson company, in a deal worth up to $1.04 billion.
The Emmes Corporation today announced that scientists and health professionals from the company, LDS Hospital in Salt Lake City, Utah, Lovelace Biomedical Environmental Research Institute in Albuquerque, New Mexico, and the U.S. Army Medical and Materiel Development Activity at Fort Detrick, Maryland, have completed a multi-year clinical trial testing hyperbaric oxygen as an intervention for U.S. military service members who have suffered mild traumatic brain injuries with persistent symptoms.
It pays to be a business in Baltimore. That’s the message that Johns Hopkins wants proprietors and their patrons to know as part of the institution’s HopkinsLocal initiative to support and invest in local enterprises.
Famous local inventor Robert E. Fischell is gifting $20 million to the University of Maryland School of Medicine in support of biomedical research.
The gift will be used to establish the Robert E. Fischell Center for Biomedical Innovation at the medical school, and provide funding for a planned new 450,000 square foot research building on the school’s Baltimore campus. It will also support research funds and endowed professorships for the new Fischell Center.
Intralytix, Inc., announced today that it has closed on the acquisition of a 33,000 sq. ft. building in Columbia, Maryland. The facility, located in the Columbia Gateway Community, will serve as the Company’s new headquarters. Plans are underway to house expanded research and laboratory space, executive offices, and substantially increased manufacturing capacity.
The University of Maryland announced its goal Friday to fundraise $1.5 billion by the end of 2021 for numerous construction projects, scholarship funds and program upgrades, according to a news release.
The government said Friday it would spend 7.5 trillion won ($7 billion) to support the biohealth sector by 2022 aggressively.
The Ministry of Trade, Industry and Energy launched “Industrial Innovation 2020 Platform” with private companies and experts to discuss cooperative measures to accelerate private sector-driven industrial innovation and growth.
Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry.
Think of The Collective as a 15K SF clubhouse for big kids. Grownups are welcome, but leave your electronic devices in your pockets, please. This is about face-to-face fun.
You’ve heard the cliché about wearing your heart on your sleeve. But a group of Army doctors did one better: They grew a new ear on a soldier’s forearm, using cartilage harvested from her ribs.
